• XAV-939 for Wnt–Barrier Mechanism Mapping

  2026-08-10

  XAV-939, also known as NVP-XAV939, is examined here as a time-resolved Wnt perturbation tool for linking endothelial cytoskeletal injury, basement-membrane degradation, and blood–brain barrier integrity. The article translates evidence from a cerebral ischemia study into practical assay decisions while defining the limits of this cross-domain application.

• Polybrene: A Smarter Variable in Gene Delivery

  2026-08-09

  Polybrene and Hexadimethrine Bromide are widely used to improve viral gene delivery, but their greatest value may come from better experimental control. This guide connects transduction design with the TCAIM–OGDH metabolism study while defining practical assay controls and interpretation limits.

• Amikacin–Lysozyme Binding: Methods and Findings

  2026-08-08

  The reference study combines tritium probing, interfacial measurements, fluorescence spectroscopy, enzymatic assays, and molecular docking to characterize how amikacin and levofloxacin interact with lysozyme. Its key distinction is that amikacin nearly eliminates lysozyme activity while preserving much of the protein’s secondary structure, whereas levofloxacin can bind near the active center without substantially perturbing catalytic residues.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-07

  Build a two-channel readout for mRNA uptake, intracellular localization, and protein expression in mammalian cells. This practical workflow uses Cy5 to track delivery and EGFP to measure translation, helping researchers compare carriers and troubleshoot delivery-system performance.

• Mapping the Shared Cell-Surface Proteome of Astrocytes and N

  2026-08-07

  Wu et al. provide the first comprehensive molecular map of cell-surface proteins shared between striatal astrocytes and neurons, revealing the cell-surface shared proteome (CS SPAN) and its alterations in Huntington’s disease. Their membrane-impermeant proximity labeling approach defines the astrocyte-neuron interface, offering a foundation for future studies of brain cell interactions in health and disease.

• Antiarrhythmic Drugs and KCa2 Channel Modulation in AF Resea

  2026-08-06

  This study systematically investigates whether commonly used antiarrhythmic agents for atrial fibrillation, including Dronedarone (Multaq), modulate small conductance calcium-activated potassium (KCa2) channels. Findings demonstrate that most clinically relevant drugs do not significantly inhibit KCa2 channels at therapeutic concentrations, highlighting the selectivity of current pharmacological strategies and informing future drug development.

• Tolazoline in Translational Research: Mechanisms, Strategy,

  2026-08-06

  This thought-leadership article explores the dual mechanistic roles and translational potential of Tolazoline as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker, articulating its strategic value for researchers in airway and metabolic disease models. Integrating recent mechanistic evidence and best practices, we provide actionable guidance for optimizing in vitro and in vivo protocols with Tolazoline, uniquely positioning APExBIO’s product as a reproducible, quantitative research asset.

• Cefazedone (Refosporen): Translational Leverage from Mechani

  2026-08-05

  This article explores the mechanistic, pharmacodynamic, and translational value of Cefazedone (Refosporen) for researchers and clinicians combating Gram-positive and Gram-negative bacterial infections. We synthesize foundational biology, in vitro and clinical evidence, competitive positioning, and actionable protocol recommendations—offering a strategic guide for maximizing the impact of this first-generation cephalosporin antibiotic in both research and therapeutic contexts.

• Fenofibrate as a PPARα Agonist: Mechanisms, Evidence, and Pr

  2026-08-05

  Fenofibrate is a potent PPARα agonist widely used in lipid metabolism and cancer biology research. It robustly activates the PPARα-YAP signaling pathway, inducing liver enlargement in both adult and aging mice without age-dependent differences. This article summarizes the mechanistic basis, evidence benchmarks, and workflow parameters for research applications.

• NS1-Driven DNMT1 Degradation Modulates Bocavirus Replication

  2026-08-04

  This study uncovers how the NS1 protein of human bocavirus 1 (HBoV1) induces degradation of the DNA methyltransferase DNMT1, thereby regulating viral DNA replication and RNA processing. The findings highlight DNMT1-mediated methylation as a crucial host factor for HBoV1 replication and suggest new avenues for antiviral strategies targeting epigenetic mechanisms.

• 25-Hydroxycholesterol-Induced AMPK Activation Shapes TAM Fun

  2026-08-04

  Xiao et al. (2024) reveal that 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), driving lysosomal AMPK activation and metabolic reprogramming via a GPR155-mTORC1 pathway. This process enhances STAT6-dependent immunosuppressive functions, suggesting new therapeutic strategies for modulating macrophage activity in the tumor microenvironment.

• DAMGO and the Central Circuits of Opioid Tolerance: Translat

  2026-08-03

  This thought-leadership article explores the central mechanisms of opioid-induced hypersensitivity and tolerance, highlighting recent advances in opioid receptor signaling research. Leveraging DAMGO—a highly selective µ-opioid receptor agonist—as a model tool, we dissect the implications of brain-to-spinal opioid pathways for translational pain research. The discussion provides strategic guidance for researchers aiming to bridge mechanistic insights with effective chronic pain models and intervention strategies.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): From Herbi

  2026-08-03

  Explore the multifaceted applications of Diuron, a high-purity photosynthesis inhibitor, in advanced toxicology and predictive renal injury research. This article uncovers mechanistic insights and protocol parameters, offering researchers a deeper perspective on assay design and environmental risk.

• Sumatriptan Metabolism: Revisiting CYP and MAO Pathways

  2026-08-02

  This study redefines the metabolic fate of sumatriptan by demonstrating that cytochrome P450 enzymes, not just monoamine oxidase A, contribute to its N-demethylation. These findings challenge prevailing assumptions in neuropharmacology and have implications for drug design and neurodegenerative disease research.

• Tropifexor Enhances Intestinal Barrier in Parenteral Nutriti

  2026-08-01

  This study demonstrates that Tropifexor (LJN452), a potent FXR agonist, significantly mitigates parenteral nutrition-induced intestinal injury in neonatal piglets. Findings highlight the compound's role in restoring epithelial barrier integrity and modulating defense response genes, with translational implications for pediatric nutrition research.

445 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page